Autres langues

03/09 Global markets live: Apple, Microsoft, Tesla, Google, Uber…
03/09 Haleon Negotiates Better Shelf Placement at Walmart, Target
03/09 Wall Street im dreifachen Würgegriff
03/09 Afternoon Meeting: La triple amenaza que se cierne sobre Wall Street
03/09 Wall Street's Triple Squeeze
03/09 FTSE 100 edges higher; oil rises above USD97
03/09 WINNERS & LOSERS: Hutchmed pens GSK deal; Gem Diamonds back in profit
03/09 Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830
03/09 Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%
03/09 Hutchmed Signs Cancer Treatment Licensing Agreement With GSK; Shares Rise Pre-Bell
03/09 LondonMetric investments; Jet2 eyes Main Market move
03/09 Morning Meeting: Comienzo sombrío de la temporada bursátil de otoño
03/09 Morning Meeting: Trüber Auftakt in den Börsenherbst
03/09 HUTCHMED Licenses Cancer Drug to GSK for Up to $1.30 Billion; Shares Up 12%
03/09 A gloomy start to the autumn trading season
03/09 HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug
03/09 Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
03/09 UK Stocks-Factors to watch on September 3
03/09 Hutchmed Grants GSK Global Rights to KRAS-EGFR Antibody Conjugate Cancer Therapy
03/09 HUTCHMED (China) signs exclusive licensing deal with GSK for investigational cancer drug
01/09 Gsk Advances Mrna Flu Vaccine Candidate to Phase Iii Following Positive Phase Ii Data
01/09 European Stocks Close Mostly Lower in Tuesday Trading; Euro Area Inflation Surges in August
01/09 Global pharma companies that have publicly announced Trump drug pricing agreements
01/09 GSK advances mRNA flu vaccine to phase 3 after positive results
01/09 GSK überführt mRNA-Grippeimpfstoff in die nächste Studienphase
Aucun résultat pour cette recherche